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ABSTRACT
Objective The difficulty in accurately assessing distance 
visual acuity (VA) at home limits the usefulness of remote 
consultation in ophthalmology. A novel web application, 
DigiVis, enables automated VA self- assessment using 
standard digital devices. This study aims to compare its 
accuracy and reliability in children with clinical assessment 
by a healthcare professional.
Methods and Analysis Children aged 4–10 years 
were recruited from a paediatric ophthalmology service. 
Those with VA worse than +0.8 logMAR (Logarithm of the 
Minimum Angle of Resolution) or with cognitive impairment 
were excluded. Bland- Altman statistics were used to 
analyse both the accuracy and repeatability of VA self- 
testing. User feedback was collected by questionnaire.
Results The left eyes of 89 children (median 7 years) 
were tested. VA self- testing showed a mean bias of 0.023 
logMAR, with a limit of agreement (LOA) of ±0.195 logMAR 
and an intraclass correlation coefficient (ICC) of 0.816. A 
second test was possible in 80 (90%) children. Test–retest 
comparison showed a mean bias of 0.010, with an LOA 
of ±0.179 logMAR, an ICC of 0.815 and a repeatability 
coefficient of 0.012. 96% of children rated the test as good 
or excellent, as did 99% of their parents.
Conclusion Digital self- testing gave comparable 
distance VA assessments with clinical testing in children 
and was well accepted. Since DigiVis self- testing can be 
performed under direct supervision using medical video 
consultation software, it may be a useful tool to enable a 
proportion of paediatric eye clinic attendances to be moved 
online, reducing time off school and releasing face- to- face 
clinical capacity for those who need it.
INTRODUCTION
Clinic backlogs were growing even before the 
COVID- 19 pandemic, but disruption during 
lockdown and ongoing social distancing 
requirements have added to clinic delays and 
the risk of preventable visual impairment. 
The potential benefits of undertaking consul-
tations remotely include reducing the burden 
of unnecessary hospital attendance on 
patients while optimising face- to- face capacity 
for those who need it. The UK NHS Long 
Term Plan aims for a third of appointments 
to become virtual to meet the demands of an 
ageing population within the constraints of 
limited clinical capacity.1 2
A distance visual acuity (VA) assessment is 
fundamental to any ophthalmic assessment, 
and a validated method for assessing VA at 
home is needed to support remote consulta-
tion.3 Although more than 20 vision testing 
applications are available, very few are clini-
cally validated, designed to be used without a 
trained observer or certified for medical use. 
Those available are difficult for the clinician 
to supervise remotely.3–7
Paediatric ophthalmology clinics have 
high footfall, with many children requiring 
frequent reviews of VA for amblyopia therapy, 
Key messages
What is already known about this subject?
 ► Distance visual acuity (VA) is fundamental to deci-
sion making in ophthalmic consultation.
 ► The NHS Long Term Plan target is for a third of con-
sultations to be undertaken remotely.
 ► Most vision testing applications are not certified 
medical devices or clinically validated.
What are the new findings?
 ► The novel web application, DigiVis, is accurate and 
repeatable in children from the age of 4 years in a 
real- world setting.
 ► The test is well accepted by parents and children.
 ► No training (other than the application’s instruction 
video) or professional support is needed for suc-
cessful self- testing.
How might these results change the focus of 
research or clinical practice?
 ► VA self- testing may be observed in real time (syn-
chronously) during video consultation to ensure 
viewing distance and eye occlusion are effective.
 ► Asynchronous testing may enable home monitoring 
of conditions such as amblyopia.
 ► Either method could reduce the frequency and re-
quirement for clinic attendance.
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resulting in time off school and expense for the family. 
An accurate system for self- testing VA which can be used 
at home may enable a proportion of paediatric appoint-
ments to be undertaken remotely.
DigiVis is a recently developed, certified medical web 
application device enabling self- testing of distance VA. 
It can be integrated within medical video consultation 
software, giving the clinician the ability to supervise the 
test to ensure that viewing distance set- up, use of glasses 
correction and effective eye occlusion are undertaken. 
In this paper, we report the accuracy and repeatability of 
DigiVis self- testing during eye clinic attendance in chil-
dren between 4 and 10 years of age.
MATERIALS AND METHODS
This was a prospective validation study comparing DigiVis 
VA self- testing with standard clinical testing. Patients and 
the public were involved in the design, conduct, reporting 
and dissemination plans of our research.
All children between 4 and 10 years of age attending 
routine paediatric ophthalmology clinic appointments 
within a 6- week period were invited to participate. 
Those with documented sight impairment of VA worse 
than +0.8 logMAR (Logarithm of the Minimum Angle 
of Resolution, 6/38 Snellen) were excluded, as were 
children with cognitive impairment. The children’s 
parents gave informed written consent and children gave 
informed verbal or written assent. Parents used DigiVis 
to self- test their children’s vision at the time of clinic 
attendance, using provided internet- connected devices 
under the supervision of a medical student. Occluding 
glasses or occlusive patches were provided but no other 
help was given. DigiVis VA results were documented by 
the student after testing and parents and children were 
asked to complete a usability and acceptance question-
naire. A standard, age- appropriate clinical assessment 
of VA was undertaken by a trained nurse, optometrist or 
orthoptist masked to DigiVis results. Where the standard 
vision assessment was undertaken using a Snellen chart, 
the value was converted to logMAR in Microsoft Excel.
The technology
The DigiVis test requires two digital devices connected 
to the internet, with no download necessary. A tablet, 
laptop or desktop computer is used to display the 
distant test chart. A paired smartphone or tablet is held 
by the child sitting 2 m away from the test chart display 
(figure 1A) and functions as an interactive ‘matching 
card’ (figure 1B). An animated instruction video in the 
application demonstrates the steps for screen calibra-
tion, measuring the viewing distance and pairing the 
devices. Sloan letter optotypes are presented on the 
larger, distant screen, with adjacent letters and indicator 
arrows providing crowding consistent with the letter size, 
in a similar manner to standard linear logMAR charts. 
Where fewer than five letters can be displayed on the 
display screen (from 0.8 logMAR), a crowding box is 
used. The child is asked to select the letter optotype out 
of a group of five displayed on their handheld device 
(four of which are randomised) which matches the letter 
indicated on the distant screen. The child is encouraged 
during the test by collecting cartoon animals after each 
correctly matched letter. Optotype sizing follows a modi-
fied García- Pérez psychophysical staircase starting at 0.6 
logMAR with three reversal points, facilitating calcula-
tion of the VA threshold.8 For this study, a lower limit of 
0.00 logMAR was set to reduce test duration for children. 
The test usually takes between 30 s and 2 min in each 
child’s eye, depending on the consistency of the subject’s 
responses. Results are displayed in logMAR, Snellen and 
ETDRS (Early Treatment Diabetic Retinopathy Study) 
chart letters.
Analysis
Data from the left eyes only were analysed to avoid 
codependence. Where standard clinical test results 
were <0.00 logMAR, the value was rounded up to 0.00 
to enable comparability with DigiVis scores. Agreement 
between DigiVis and clinical VA measurements as well 
as test–retest (TRT) agreement were evaluated with 
Bland- Altman plots, looking specifically at 95% limits 
of agreement (LOA) and mean bias, and with intraclass 
correlation coefficients (ICC) and repeatability coeffi-
cients. A priori standards were used to facilitate appraisal 
of agreement as quantified by ICC.9 Analysis and data 
visualisation were conducted in R (V.3.6.1; R Foundation 
for Statistical Computing, Vienna, Austria) and Affinity 
Designer (V.1.8.6; Pantone, Carlstadt, New Jersey, USA).
RESULTS
The left eyes of 89 children 4–10 years of age (mean 
7.4 years, median 7 years) were tested using the chil-
dren’s version of the DigiVis app and by standard, 
age- appropriate clinical assessment. Of these children, 
80 (90%) completed two DigiVis tests, enabling TRT 
agreement to be appraised. Subject VA based on stan-
dard clinical testing ranged from 0 to 0.8 logMAR (mean 
0.09 logMAR; IQR 0–0.13 logMAR).
Figure 1 (A) Randomised optotype presentation on the 
distant device; the arrow indicates the letter to match. (B) 
The appearance of randomised letters on the handheld 
device, one of which matches the indicated letter on the 
distant test chart. The ‘not sure’ button registers as an 
incorrect attempt.
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In both comparisons, good agreement is indicated 
by ICC values (p<0.001) and repeatability coefficients 
(table 1). Bland- Altman plots feature an average LOA 
at ±0.195 logMAR for accuracy, comparing DigiVis and 
clinical assessment (figure 2), and ±0.179 logMAR for 
TRT agreement (figure 3). Bias was minimal in both 
cases, indicating a lack of systematic error between 
measurement techniques in both comparisons. No signif-
icant correlation (p>0.1) was observed between mean 
VA and difference in VA in either Bland- Altman plot, 
suggesting that agreement was consistent over the tested 
range. Repeatability coefficients suggest that the smallest 
detectable difference in vision with DigiVis is around 
0.012 logMAR (table 1).
Of 89 children, 85 (95.6%) rated the test as good or 
excellent, as did 88 of the 89 (98.9%) parents. Of the 89 
parents, 86 (96.7%) said that they would consider using 
the test to monitor their child’s vision at home.
DISCUSSION
Conventional chart- based assessment of VA in children 
aged 6–11 years with corrected VA of 0.20 logMAR or better 
has reported a TRT LOA of ±0.15 logMAR.10 Validated 
digital distance VA testing systems include Peek Acuity, 
with an LOA between the app and clinical measurements 
of ±0.444 logMAR and a TRT LOA of ±0.414 logMAR.6 
COMPlog, a distance VA test requiring a specifically sized 
computer monitor, recorded a TRT LOA  ±0.10–0.12 
logMAR and an ICC of 0.964 in adults when comparing 
face- to- face with remote testing.11 12 Digital Kay picture 
symbol testing in children has an LOA between the app 
and ETDRS chart of ±0.21 and a TRT LOA of ±0.14.13 
Together, these data provide a priori standards against 
which DigiVis can be evaluated, although it should be 
noted that these validation studies used trained exam-
iners to assess visual threshold rather than self- testing.
In this study, self- assessment with DigiVis, without 
trained input from an eyecare professional, had minimal 
bias, LOA of ±0.195 logMAR when compared with stan-
dard clinical testing, and TRT LOA of ±0.179 logMAR, 
with high ICC values of 0.816 and 0.815 and low repeat-
ability coefficients, reinforcing evidence of its accuracy 
and reliability. The narrowness of CIs for calculated statis-
tics suggests that the sampled population was sufficiently 
large to provide robust results.
There were several limitations to this study. Standard 
clinical testing was carried out using a variety of stan-
dard charts: Snellen, ETDRS and children’s logMAR flip 
charts. This reflects real- world variation in paediatric 
ophthalmology clinics but may have reduced the reli-
ability of clinical measurements. A potential advantage 
of DigiVis is that it provides uniformity of testing from 
4 years upwards and removes observer bias. A further 
limitation of this analysis was the exclusion of children 
with VA worse than +0.8 logMAR, a decision made due 
to the presumed difficulties these individuals may have 
in accessing the test. Additionally, the IQR of 0.00–0.13 
logMAR illustrates bias towards good VA levels in the 
studied population. Further investigation is required to 
Table 1 Mean bias and LOA for DigiVis compared with standard clinical assessment of VA and TRT agreement with 95% CI
Mean bias (95% CI) logMAR
Upper LOA (95% CI) 







0.023 (0.002 to 0.044) 0.218 (0.182 to 0.254) −0.172 (−0.208 to −0.136) 0.816 (0.748 to 0.869) 0.014
DigiVis TRT 
agreement
0.010 (−0.010 to 0.030) 0.189 (0.154 to 0.223) −0.168 (−0.203 to −0.134) 0.815 (0.733 to 0.845) 0.012
LOA, limits of agreement; logMAR, Logarithm of the Minimum Angle of Resolution; TRT, test–retest; VA, visual acuity.
Figure 2 Bland- Altman plot comparing DigiVis visual 
acuity measurements with standard clinical testing to 
evaluate accuracy. The bias and 95% limits of agreement 
(dashed lines) are labelled and have 95% CIs (dotted lines) 
shaded. LOA, limits of agreement. logMAR, Logarithm of the 
Minimum Angle of Resolution.
Figure 3 Bland- Altman plot comparing repeated DigiVis 
measurements to evaluate test–retest agreement. The bias 
and 95% LOA (dashed lines) are labelled and have 95% CIs 
(dotted lines) shaded. LOA, limits of agreement. logMAR, 
Logarithm of the Minimum Angle of Resolution.
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verify the app’s potential in children with poorer VA levels 
since they were under- represented in this study. Children 
with special educational needs and developmental delay 
were also excluded from this study since prior attempts to 
use DigiVis in children with Down syndrome had failed 
due to difficulty in understanding the concept of letter 
matching. Finally, the apparent consistency of DigiVis in 
tested subjects may have been inflated by the study partic-
ipants repeating the test in quick succession, in the same 
testing environment and on the same devices. However, 
rapid retesting of children might also have been expected 
to result in poorer concentration and less repeatability.
Despite the limitations of the study, the results indicate 
that self- testing with DigiVis is comparable with age- 
appropriate VA assessment by a trained examiner in this 
childhood population, agreeing with our findings in a 
wider population containing older children and adults.14 
The accuracy of VA assessment is dependent on viewing 
distance, correct use of glasses and effective occlusion. 
Confidence in home testing results may be improved by 
synchronising testing with remote consultation, using the 
share screen function of medical video conferencing soft-
ware. This enables the clinician to observe test set- up and 
directly monitor both the child’s performance and the 
test chart in the conferencing window in real time. Based 
on the clinician’s observation and satisfaction with the 
parent and child’s ability to undertake the synchronised 
test effectively, unsupervised asynchronous home moni-
toring of VA may be considered. This could reduce the 
need for children to miss school in order to attend a 
face- to- face consultation. Further studies to determine 
the take- up and accuracy of both synchronous and asyn-
chronous home vision self- testing using DigiVis are in 
progress. Vision self- testing was well accepted by both 
children and parents in this study, with almost all willing 
to use it for future home monitoring. Home testing and 
monitoring may encourage parents to take a more active 
role in their child’s eyecare and clinical capacity could be 
freed for children needing face- to- face clinic time.
A disadvantage of DigiVis is its need for the family to 
have two internet- connected devices. Although most 
young families will have a smartphone and a tablet, a 
proportion of families will not be able to access the test. 
There is a recognised relationship between digital exclu-
sion and the risk of poor health; inability to access digital 
testing could flag up this risk and prioritise access for 
face- to- face appointments.15
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